Table of Contents United States Meningococcal Infections Vaccine Market Report 2018 1 Meningococcal Infections Vaccine Overview 1.1 Product Overview and Scope of Meningococcal Infections Vaccine 1.2 Classification of Meningococcal Infections Vaccine by Product Category 1.2.1 United States Meningococcal Infections Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States Meningococcal Infections Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 Meningococcal Conjugate Vaccines 1.2.4 Meningococcal Polysaccharide Vaccine 1.2.5 Serogroup B Meningococcal Vaccine 1.3 United States Meningococcal Infections Vaccine Market by Application/End Users 1.3.1 United States Meningococcal Infections Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 Children 1.3.3 Preteens/Teens 1.3.4 Adults 1.4 United States Meningococcal Infections Vaccine Market by Region 1.4.1 United States Meningococcal Infections Vaccine Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West Meningococcal Infections Vaccine Status and Prospect (2013-2025) 1.4.3 Southwest Meningococcal Infections Vaccine Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic Meningococcal Infections Vaccine Status and Prospect (2013-2025) 1.4.5 New England Meningococcal Infections Vaccine Status and Prospect (2013-2025) 1.4.6 The South Meningococcal Infections Vaccine Status and Prospect (2013-2025) 1.4.7 The Midwest Meningococcal Infections Vaccine Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of Meningococcal Infections Vaccine (2013-2025) 1.5.1 United States Meningococcal Infections Vaccine Sales and Growth Rate (2013-2025) 1.5.2 United States Meningococcal Infections Vaccine Revenue and Growth Rate (2013-2025) 2 United States Meningococcal Infections Vaccine Market Competition by Players/Suppliers 2.1 United States Meningococcal Infections Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States Meningococcal Infections Vaccine Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States Meningococcal Infections Vaccine Average Price by Players/Suppliers (2013-2018) 2.4 United States Meningococcal Infections Vaccine Market Competitive Situation and Trends 2.4.1 United States Meningococcal Infections Vaccine Market Concentration Rate 2.4.2 United States Meningococcal Infections Vaccine Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Meningococcal Infections Vaccine Manufacturing Base Distribution, Sales Area, Product Type 3 United States Meningococcal Infections Vaccine Sales (Volume) and Revenue (Value

List of Tables and Figures Figure Product Picture of Meningococcal Infections Vaccine Figure United States Meningococcal Infections Vaccine Market Size (K doses) by Type (2013-2025) Figure United States Meningococcal Infections Vaccine Sales Volume Market Share by Type (Product Category) in 2017 Figure Meningococcal Conjugate Vaccines Product Picture Figure Meningococcal Polysaccharide Vaccine Product Picture Figure Serogroup B Meningococcal Vaccine Product Picture Figure United States Meningococcal Infections Vaccine Market Size (K doses) by Application (2013-2025) Figure United States Sales Market Share of Meningococcal Infections Vaccine by Application in 2017 Figure Children Examples Table Key Downstream Customer in Children Figure Preteens/Teens Examples Table Key Downstream Customer in Preteens/Teens Figure Adults Examples Table Key Downstream Customer in Adults Figure United States Meningococcal Infections Vaccine Market Size (Million USD) by Region (2013-2025) Figure The West Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025) Figure New England Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2013-2025) Figure United States Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Meningococcal Infections Vaccine Market Major Players Product Sales Volume (K doses) (2013-2018) Table United States Meningococcal Infections Vaccine Sales (K doses) of Key Players/Suppliers (2013-2018) Table United States Meningococcal Infections Vaccine Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States Meningococcal Infections Vaccine Sales Share by Players/Suppliers Figure 2017 United States Meningococcal Infections Vaccine Sales Share by Players/Suppliers Figure United States Meningococcal Infections Vaccine Market Major Players Product Revenue (Million USD) (2013-2018) Table United States Meningococcal Infections Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States Meningococcal Infections Vaccine Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States Meningococcal Infections Vaccine Revenue Share by Players/Suppliers Figure 2017 United States Meningococcal Infections Vaccine Revenue Share by Players/Suppliers Table United States Market Meningococcal